Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13120
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAngus, Peter W-
dc.contributor.authorLocarnini, S A-
dc.contributor.authorMcCaughan, Geoffrey W-
dc.contributor.authorJones, Robert M-
dc.contributor.authorMcMillan, J S-
dc.contributor.authorBowden, D S-
dc.date.accessioned2015-05-16T02:54:17Z
dc.date.available2015-05-16T02:54:17Z
dc.date.issued1995-01-01-
dc.identifier.citationHepatology (baltimore, Md.); 21(1): 14-8en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13120en
dc.description.abstractThe factors that predispose patients undergoing liver transplantation for hepatitis B virus (HBV) disease to severe recurrence of infection are unclear. In this study we examined the effect of pretransplantation infection with HBV and precore variant strains of HBV on posttransplantation outcome and allograft histology in 24 patients who survived more than 3 months after liver transplantation. Based on pretransplantation serum HBV DNA status as detected by the polymerase chain reaction (PCR) and direct sequencing, the 24 patients could be assigned to three groups. In group 1 there were 4 patients HBV DNA-negative before transplantation and none of these patients suffered recurrence of infection posttransplantation. In group 2, of 10 patients with pretransplantation infection with wild-type virus, 7 became reinfected, and 1 of these developed HBV-related graft failure. In group 3, 9 of 10 patients infected with precore mutant HBV strains became reinfected. However, in contrast to the patients in group 2, 7 patients in group 3 developed HBV-related graft loss, and 5 of these patients had fibrosing cholestatic hepatitis (FCH). These results indicate that infection with precore mutant strains of HBV predisposes a patient to early graft loss following transplantation.en_US
dc.language.isoenen
dc.subject.otherCholestasis.etiologyen
dc.subject.otherDNA, Viral.analysisen
dc.subject.otherGraft Rejectionen
dc.subject.otherHepatitis B.complications.genetics.surgeryen
dc.subject.otherHepatitis B Core Antigens.geneticsen
dc.subject.otherHumansen
dc.subject.otherLiver Transplantationen
dc.subject.otherMutationen
dc.subject.otherPostoperative Perioden
dc.subject.otherRecurrenceen
dc.subject.otherSurvival Analysisen
dc.titleHepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleHepatology (Baltimore, Md.)en_US
dc.identifier.affiliationVictorian Liver Transplant Uniten_US
dc.description.pages14-8en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7806147en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherAngus, Peter W
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptHepatopancreatobiliary Surgery-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.